Ardelyx reported $85K in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
TG Therapeutics TGTX:US 237K 27K
Abbott ABT:US $ 4987M 267M
Amgen AMGN:US $ 1561M 157M
Ardelyx ARDX:US $ 0.08M 0.08M
Astrazeneca AZN:US 2.28B 790M
Biocept BIOC:US $ 10.34M 0.3M
Corcept Therapeutics CORT:US $ 1.25M 0.1M
Curis CRIS:US $ 0.08M 0.08M
Opko Health OPK:US $ 243.88M 48.95M
United Therapeutics UTHR:US $ 25.9M 8.7M